{"name":"Finn Gustafsson","slug":"finn-gustafsson","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Standard heart failure medical therapy","genericName":"Standard heart failure medical therapy","slug":"standard-heart-failure-medical-therapy","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Standard heart failure medical therapy","genericName":"Standard heart failure medical therapy","slug":"standard-heart-failure-medical-therapy","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE9nOERSbWNZVzhOalFHVENtUFlfNUE3MElaT3RRdjRkWkdjUEx6ZDNIM0U3bEg3UEh4X0hiX000QXhHSWI4R2Rac2ZvcXBKZUNVbVpuSDUzTDBlU1J1QnZtUkRJYTBuTUlKbXZN?oc=5","date":"2025-09-19","type":"pipeline","source":"Wiley Online Library","summary":"SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI - Wiley Online Library","headline":"SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE12cml3UEFTY2lIX19TTlpMalN5WVc0cnpoaS1XQjdldUhYMlExdXBONkZaY1o3MkVBUUZfdnJnQWgtQnBnZjhKRmozWnc1YThaVUotal8ydXlUY1M5NlN6UUFESnYwbTVyanBWWWlhaExvZTdSdUpr?oc=5","date":"2025-04-08","type":"pipeline","source":"MassDevice","summary":"Abbott bolsters its Heart Failure leadership - MassDevice","headline":"Abbott bolsters its Heart Failure leadership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9NajFJaVBxbENsMWZQSzJqT29va19iZTgydm5uRGJKNndtV3VpRldVQjZMQWtQeDAtZHFlYWJiZi1XbUx6VndVb3hTRmROQ1RESkhxYjFTbHhzZV92WHNtenNLbkw0S0s2QUZRdmpfYkI4QlQxb2VFZFpPOEs?oc=5","date":"2022-11-09","type":"pipeline","source":"European Medical Journal","summary":"The Future of Heart Failure: LVAD - European Medical Journal","headline":"The Future of Heart Failure: LVAD","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}